อื่นที่อาจส่งผลกระทบต่อกองทุนด้วย เช่น ต้นทุนในการทำรายการที่เกี่ยวข้องโดยตรงเพื่อให้ได้มาซึ่งเงินลงทุน (transaction cost) ที่วัดมูลค่ายุติธรรมผ่านกำไรขาดทุน โดยมาตรฐาน TFRS 9 กำหนดให้บันทึกบัญชีเป็นค่า
6.01 Total Revenues 298.26 604.18 1,018.60 1,620.84 797.50 Costs 203.56 321.20 580.70 856.82 380.02 Selling And Administrative Expenses 82.93 57.10 126.84 433.21 329.69 Total Cost And Expenses 287.42
104.63 206.40 232.50 330.41 Total Cost And Expenses 311.97 308.01 612.69 648.10 873.08 EBITDA 70.47 199.96 277.07 64.54 -19.22 Depre. & Amor. 14.42 14.78 29.14 29.35 25.41 EBIT 56.05 185.18 247.93 35.19
471.03 668.85 401.84 Selling And Administrative Expenses 44.12 112.70 161.64 247.38 133.74 Total Cost And Expenses 122.03 386.45 572.98 870.76 78.51 EBITDA 10.40 -47.11 19.76 134.41 483.00 Depre. & Amor
2,254.65 1,922.99 Selling And Administrative Expenses 112.52 128.05 256.49 245.94 215.37 Total Cost And Expenses 1,095.20 1,256.17 2,394.68 2,500.59 2,138.36 EBITDA 71.01 159.07 254.41 549.74 493.24 Depre
2.65 18.46 20.05 0.55 0.68 Total Revenues 119.51 1,255.10 1,299.57 200.39 68.87 Costs 75.03 1,032.76 1,064.29 120.68 36.28 Selling And Administrative Expenses 14.41 86.73 133.98 38.38 15.52 Total Cost
86.83 60.01 53.84 Total Cost And Expenses 1,224.96 1,057.21 2,208.97 1,909.75 1,078.69 EBITDA 100.53 100.06 172.74 220.32 181.44 Depre. & Amor. 49.29 51.83 100.73 94.89 76.40 EBIT 51.24 48.23 72.01 125.43
shall not be effected, which increase the efficiency in managing its cost. The Office, therefore, has amended the prescription concerning working procedures and conditions for securities company on using
increase the efficiency in managing its cost. The Office, therefore, has amended the prescription concerning working procedures and conditions for securities company on using back office service from service
shall not be effected, which increase the efficiency in managing its cost. The Office, therefore, has amended the prescription concerning working procedures and conditions for securities company on using